Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine

44Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

Abstract

Background: The study describes the molecular epidemiology of Streptococcus pneumoniae causing invasive disease in Gambian children Methods: One hundred and thirty-two S. pneumoniae isolates were recovered from children aged 2-29 months during the course of a pneumococcal conjugate vaccine trial conducted in The Gambia of which 131 were characterized by serotyping, antibiotic susceptibility, BOX-PCR and MLST. Results: Twenty-nine different serotypes were identified; serotypes 14, 19A, 12F, 5, 23F, and 1 were common and accounted for 58.3% of all serotypes overall. MLST analysis showed 72 sequence types (STs) of which 46 are novel. eBURST analysis using the stringent 6/7 identical loci definition, grouped the isolates into 17 clonal complexes and 32 singletons. The population structure of the 8 serotype 1 isolates obtained from 4 vaccinated and 2 unvaccinated children were the same (ST 618) except that one (ST3336) of the isolates from an unvaccinated child had a novel ST which is a single locus variant of ST 618. Conclusion: We provide the first background data on the genetic structure of S. pneumoniae causing IPD prior to PC7V use in The Gambia. This data will be important for assessing the impact of PC7V in post-vaccine surveillance from The Gambia. © 2008 Antonio et al; licensee BioMed Central Ltd.

References Powered by Scopus

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: Randomised, double-blind, placebo-controlled trial

801Citations
N/AReaders
Get full text

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

774Citations
N/AReaders
Get full text

Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I

757Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis

303Citations
N/AReaders
Get full text

Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: A systematic review

132Citations
N/AReaders
Get full text

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

77Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Antonio, M., Dada-Adegbola, H., Biney, E., Awine, T., O’Callaghan, J., Pfluger, V., … Adegbola, R. A. (2008). Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infectious Diseases, 8. https://doi.org/10.1186/1471-2334-8-81

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 26

58%

Researcher 12

27%

Professor / Associate Prof. 5

11%

Lecturer / Post doc 2

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

50%

Agricultural and Biological Sciences 12

27%

Immunology and Microbiology 7

16%

Nursing and Health Professions 3

7%

Save time finding and organizing research with Mendeley

Sign up for free